AGENUS INC Contracts & Agreements

Purchase and Sale Agreement, dated as of May 6, 2024, by and between Agenus Inc., Agenus Royalty Fund, LLC, Agenus Holdings 2024, LLC, and Ligand Pharmaceuticals Incorporated (Filed With SEC on August 8, 2024)

Form of 2024 A Warrant (Filed With SEC on May 7, 2024)

Amendment to Consulting Agreement between Agenus Inc. and Brian Corvese, dated December 31, 2023 (Filed With SEC on March 14, 2024)

Form of 2022 A Warrant (Filed With SEC on December 2, 2022)

Form of 2022 B Warrant (Filed With SEC on December 2, 2022)

Executive Employment Agreement dated October 27, 2020 between Agenus Inc. and Steven ODay (Filed With SEC on May 10, 2022)

Consulting Agreement dated January 1, 2022 between Agenus Inc. and Jennifer Buell (Filed With SEC on May 10, 2022)

Amendment to the Agenus Inc. 2019 Equity Incentive Plan, dated February 2, 2022 (Filed With SEC on March 1, 2022)

Amendment to Consulting Agreement between Agenus Inc. and Brian Corvese, dated January 1, 2022 (Filed With SEC on March 1, 2022)

Consulting Agreement dated April 30, 2021 between Agenus Inc. and Evan Kearns (Filed With SEC on March 1, 2022)

Amendment to Consulting Agreement between Agenus Inc. and Evan Kearns, dated January 31, 2022 (Filed With SEC on March 1, 2022)

License, Development and Commercialization Agreement, dated May 17, 2021, by and between Agenus Inc. and Bristol Myers Squibb Company (Filed With SEC on August 9, 2021)

Amendment No. 1 to Royalty Purchase Agreement, dated June 22, 2021, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on August 9, 2021)

Office Lease by and between Bay Center Investor LLC and Agenus Inc. dated November 25, 2020 (Filed With SEC on November 25, 2020)

Executive Employment Agreement dated November 6, 2020, by and between Agenus Inc. and Evan Kearns (Filed With SEC on November 9, 2020)

Stock Purchase Agreement, dated as of June 20, 2020, by and among Agenus Inc., Betta Investment (Hong Kong) Limited, and Betta Pharmaceuticals Co., Ltd (Filed With SEC on August 10, 2020)

License and Collaboration Agreement, dated as of June 20, 2020, by and between Agenus Inc. and Betta Pharmaceuticals Co., Ltd (Filed With SEC on August 10, 2020)

Consulting Agreement dated January 1, 2020 between Agenus Inc. and Brian Corvese (Filed With SEC on May 11, 2020)

Form of Incentive Stock Option Agreement for the Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on March 16, 2020)

Form of Non-Qualified Stock Option Agreement for the Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on March 16, 2020)

Form of Restricted Stock Unit Award Agreement for the Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on March 16, 2020)

Amendment to Notes and Warrants dated as of February 18, 2020 by and among Agenus Inc. and the Investors listed therein (Filed With SEC on March 16, 2020)

Form of Warrant under the Amended and Restated Note Purchase Agreement dated as of February 18, 2020 (Filed With SEC on March 16, 2020)

Description of Securities (Filed With SEC on March 16, 2020)

Executive Employment Agreement dated August 8, 2019, by and between Agenus Inc. and Dr. Jennifer Buell (Filed With SEC on August 9, 2019)

Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on June 24, 2019)

Stock Purchase Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

License Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

Option and License Agreement (AGEN1223) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

Option and License Agreement (AGEN2373) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

Royalty Purchase Agreement dated September 20, 2018, by and among Agenus Inc., Agenus Royalty Fund, LLC and XOMA (US) LLC (Filed With SEC on November 7, 2018)

Amendment No.1 to Consulting Agreement, effective July 1, 2018, by and between Agenus Inc. and Dr. Robert Stein (Filed With SEC on November 7, 2018)

Consulting Agreement, effective July 1, 2018, as amended, by and between AgenTus Therapeutics, Inc. and Dr. Robert Stein (Filed With SEC on November 7, 2018)

Consulting Agreement dated July 12, 2018, by and between Agenus Inc. and Karen Valentine (Filed With SEC on November 7, 2018)

Stock Purchase Agreement, dated October 10, 2018, between the Company and the purchasers listed on Exhibit A thereto (Filed With SEC on October 11, 2018)

Sales Agreement dated May 11, 2018 by and between Agenus Inc. and B. Riley FBR, Inc (Filed With SEC on May 11, 2018)

Royalty Purchase Agreement dated January 6, 2018, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on May 10, 2018)

Contract of Employment dated February 1, 2016, by and between Agenus UK Limited and Alex Duncan (Filed With SEC on May 10, 2018)

Change of Control Agreement dated February 1, 2016, by and between Agenus Inc. and Alex Duncan (Filed With SEC on May 10, 2018)

Separation Agreement dated December 19, 2017, by and between Agenus Inc. and Jean-Marie Cuillerot (Filed With SEC on May 10, 2018)

DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on August 7, 2017)

stock PURCHASE AGREEMENT (Filed With SEC on May 4, 2017)

FIRST AMENDMENT TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 4, 2017)

CONSULTING AGREEMENT (Filed With SEC on May 4, 2017)

AMENDMENT TO NOTES AND WARRANTS (Filed With SEC on March 16, 2017)

AGREEMENT (Filed With SEC on March 16, 2017)

AGENUS AMENDED ANDRESTATED 2009 EQUITY INCENTIVE PLAN (as of April 8, 2016) (Filed With SEC on June 16, 2016)

AGENUS INC. 2016EXECUTIVE INCENTIVE PLAN (Filed With SEC on June 16, 2016)

license agreement University of Virginia Licensing & Ventures Group PhosImmune, Inc. (Filed With SEC on March 15, 2016)

LICENSE AGREEMENT (Filed With SEC on March 15, 2016)

PURCHASE AGREEMENT, dated as of December 23, 2015 by and among AgenusInc., a Delaware corporation, as the Purchaser, PhosImmune Inc., a Virginia corporation, as the Company, the... (Filed With SEC on December 23, 2015)

NOTE PURCHASEAGREEMENT DATED SEPTEMBER 4, 2015 among ANTIGENICS LLC, THE GUARANTORS NAMED HEREIN, OBERLAND CAPITAL SA ZERMATT LLC, AS COLLATERAL AGENT AND THE PURCHASERSNAMED... (Filed With SEC on September 11, 2015)

ANTIGENICS LLC LIMITEDRECOURSE NOTE (Filed With SEC on September 11, 2015)

REVENUE INTEREST ASSIGNMENT AND TERMINATION AGREEMENT dated as of September 4, 2015 between INGALLS & SNYDER VALUE PARTNERS, L.P. ARTHUR KOENIG AGENUSINC. and ANTIGENICS LLC Table... (Filed With SEC on September 11, 2015)

AGENUS INC. NON-QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENT (Filed With SEC on August 3, 2015)

AGREEMENT (Filed With SEC on June 30, 2015)

AGENUS INC. RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on June 30, 2015)

FOURTH AMENDMENT TO AGENUS 2009 EQUITY INCENTIVE PLAN (Filed With SEC on June 30, 2015)

3 Forbes Road, Lexington, MA 02421 ***@*** (Filed With SEC on June 17, 2015)

AGENUS INC. 11,000,000 Shares of Common Stock1 UNDERWRITING AGREEMENT (Filed With SEC on May 27, 2015)

AMENDED AND RESTATED NOTE PURCHASE AGREEMENT by and among AGENUS INC., and the PURCHASERS named herein Dated: February 20, 2015 Amended: February 25, 2015 (Filed With SEC on May 1, 2015)

FORM OF SENIOR SUBORDINATED NOTE (Filed With SEC on May 1, 2015)

FORM OF WARRANT (Filed With SEC on May 1, 2015)

ASSET PURCHASE AGREEMENT by and between AGENUS INC., CELEXION, LLC and THE MEMBERS OF CELEXION dated as of April 7, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on April 8, 2015)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)

LICENSE AGREEMENT (Filed With SEC on March 16, 2015)

LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN AGENUS INC., 4-ANTIBODY AG, INCYTE EUROPE SARL, AND INCYTE CORPORATION, SOLELY FOR PURPOSES OF SECTION 12.16 (Filed With SEC on March 16, 2015)

COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT (Filed With SEC on May 9, 2014)

COLLABORATIVE RESEARCH & DEVELOPMENT AND COMMERCIAL RIGHTS AGREEMENT (Filed With SEC on May 9, 2014)

SUBLEASE AGREEMENT for office spaces in the property Technologie Park Basel AG (information) at the Stcki Business Park Hochbergerstrasse 60C, 4057 Basel (Filed With SEC on May 9, 2014)

Addendum to the Lease Agreement from 01/28/2011 between 4-Antibody AG, Hochbergerstr. 60C, 4057 Basel (Sublessee) and Technologie Park Basel AG, c/o Amt fr Wirtschaft und Arbeit... (Filed With SEC on May 9, 2014)

Addendum No. 4 to the Lease Agreement from 01/28/2011 between 4-Antibody AG, Hochbergerstr. 60C, 4057 Basel (Sublessee) and Technologie Park Basel AG, Hochbergerstr. 60C, 4057... (Filed With SEC on May 9, 2014)

Addendum No. 5 to the Lease Agreement from 01/28/2011 between 4-Antibody AG, Hochbergerstr. 60C, 4057 Basel (Sublessee) and Technologie Park Basel AG, Hochbergerstr. 60C, 4057... (Filed With SEC on May 9, 2014)

Addendum No. 6 to the Lease Agreement from 01/28/2011 between 4-Antibody AG, Hochbergerstr. 60C, 4057 Basel (Sublessee) and Technologie Park Basel AG, Hochbergerstr. 60C, 4057... (Filed With SEC on May 9, 2014)

Commercial Lease Agreement No. 01/2003 (Filed With SEC on May 9, 2014)

20th Addendum to Lease Agreement No. 01/2003 from 12/01/2002 (Filed With SEC on May 9, 2014)

28th Addendum to Lease Agreement No. 01/2003 from 12/01/2002 (Filed With SEC on May 9, 2014)

29th Addendum to Lease Agreement No. 01/2003 from 12/01/2002 (Filed With SEC on May 9, 2014)

AMENDMENT NO. THREE TO AGENUS 2009 EQUITY INCENTIVE PLAN (Filed With SEC on April 25, 2014)

AGENUS INC. 19,335,653 Shares of Common Stock1 UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2014)

SHARE EXCHANGE AGREEMENT dated as of January 10, 2014 by and among Agenus Inc., a Delaware corporation, as Purchaser, 4-Antibody AG, a joint stock company under the laws of... (Filed With SEC on January 13, 2014)

H.C. Wainwright &Co., LLC 430 Park Avenue, New York, New York 10022 ###-###-#### www.hcwco.com Member: FINRA, SIPC 1 (Filed With SEC on September 19, 2013)

COMMON STOCK PURCHASE WARRANT AGENUS INC. (Filed With SEC on September 19, 2013)

SECURITIES PURCHASE AGREEMENT (as amended to date) (Filed With SEC on September 19, 2013)

AMENDMENT NO. 2 TO AGENUS 2009 EQUITY INCENTIVE PLAN (Filed With SEC on June 17, 2013)

CONFIDENTIAL TREATMENT MATERIAL (Filed With SEC on May 10, 2013)

[FORM OF] SENIOR SUBORDINATED NOTE (Filed With SEC on May 10, 2013)

WARRANT (Filed With SEC on May 10, 2013)

CONFIDENTIAL TREATMENT MATERIAL CONFIDENTIAL TREATMENT REQUESTED: Information for which confidential treatment has been requested is omitted and is noted with asterisks. An... (Filed With SEC on May 10, 2013)

AGENUS INC. SECURITIES EXCHANGE AGREEMENT APRIL 15, 2013 AGENUS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on May 10, 2013)

CONFIDENTIAL TREATMENT MATERIAL CONFIDENTIAL TREATMENT REQUESTED: Information for which confidential treatment has been requested is omitted and is noted with asterisks. An... (Filed With SEC on May 10, 2013)

AGENUS INC. 2009 EQUITY INCENTIVE PLAN (As amended through June 13, 2012) (Filed With SEC on March 18, 2013)

AGENUS INC. DIRECTORS DEFERRED COMPENSATION PLAN (As amended through June 13, 2012) ARTICLE I GENERAL (Filed With SEC on March 18, 2013)

STANDARD FORM OF OFFICE LEASE The Real Estate Board of New York, Inc. (Filed With SEC on March 18, 2013)

[AGENUS LETTERHEAD] (Filed With SEC on February 5, 2013)

FIRST RIGHT TO NEGOTIATE AND AMENDMENT AGREEMENT (Filed With SEC on May 9, 2012)

LICENSE AND DEVELOPMENT AND MANUFACTURING TECHNOLOGY TRANSFER AGREEMENT (Filed With SEC on March 6, 2012)

AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on March 2, 2012)

AGENUS INC. Board Compensation Election Policy (Filed With SEC on November 4, 2011)

AGENUS INC. 13,725,491 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2011)

FIFTH AMENDMENT OF LEASE (Filed With SEC on May 6, 2011)

AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE (Filed With SEC on March 16, 2011)

AGENUS INC. Ninth Amendment of Rights RECITALS (Filed With SEC on March 16, 2011)

AMENDMENT NUMBER TWO TO EMPLOYMENT AGREEMENT December 15, 2010 (Filed With SEC on March 16, 2011)

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT December 15, 2010 (Filed With SEC on March 16, 2011)

AMENDMENT NUMBER TWO TO EMPLOYMENT AGREEMENT December 15, 2010 (Filed With SEC on March 16, 2011)

ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on March 16, 2011)

ANTIGENICS INC. SECURITIES REPURCHASE AGREEMENT (Filed With SEC on March 16, 2011)

ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on March 16, 2011)

AGENUS INC. 2004 EXECUTIVE INCENTIVE PLAN, AS AMENDED (Filed With SEC on January 27, 2011)

AGENUS INC. (Filed With SEC on January 6, 2011)

SCHEDULE TO INDEMNIFICATION AGREEMENT (Filed With SEC on March 15, 2010)

ANTIGENICS INC. 20,000,000 Shares Of Common Stock At Market Issuance Sales Agreement (Filed With SEC on March 1, 2010)

ANTIGENICS, INC. Waiver of Rights Upon Issuance of OtherSecurities RECITALS (Filed With SEC on November 9, 2009)

ANTIGENICS INC. Waiver of Rights Upon Issuance of OtherSecurities RECITALS (Filed With SEC on November 9, 2009)

AMENDMENT NUMBER ONE AGREEMENT (Filed With SEC on November 9, 2009)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on November 9, 2009)

NOTIFICATION OF SHIPMENT (Filed With SEC on November 9, 2009)

ANTIGENICS, INC. Second Amendment of Rights with respect to Events of Default and Issuance ofOther Securities RECITALS (Filed With SEC on August 10, 2009)

ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENT (Filed With SEC on August 10, 2009)

Amendment No. 2 to Master Services Agreement (Filed With SEC on August 10, 2009)

AMENDMENT NUMBER TWO LICENSE AGREEMENT (Filed With SEC on August 10, 2009)

EXHIBIT A Basic Principles for the Agreement (Filed With SEC on August 10, 2009)

WARRANT (Filed With SEC on August 5, 2009)

ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 5, 2009)

WARRANT (Filed With SEC on August 3, 2009)

ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 3, 2009)

ANTIGENICS INC. AMENDED AND RESTATED EXECUTIVE CHANGE OF CONTROL PLAN (Filed With SEC on June 15, 2009)

ANTIGENICS INC. RESTRICTED STOCK AWARDAGREEMENT (Filed With SEC on June 15, 2009)

ANTIGENICS INC. [INCENTIVE] STOCK OPTIONAGREEMENT [STAGED EXERCISABILITY] (Filed With SEC on June 15, 2009)

AMENDED AND RESTATED MANUFACTURING TECHNOLOGY TRANSFER AND (Filed With SEC on May 11, 2009)

Second Amendment to Exhibit A-5 to MasterServices Agreement (Filed With SEC on May 11, 2009)

ANTIGENICS, INC. Amendment of Rights with respect to Events of Default and Issuance of OtherSecurities RECITALS (Filed With SEC on May 11, 2009)

ANTIGENICS INC. 1999 EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on March 16, 2009)

FOURTH AMENDMENT OF LEASE (Filed With SEC on November 5, 2008)

AGREEMENT (Filed With SEC on September 19, 2008)

AMENDMENT NO. 8 TO THE PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on August 8, 2008)

THIRD AMENDMENT OF LEASE (Filed With SEC on August 8, 2008)

Amendment to Exhibit A-5 to Master Services Agreement (Filed With SEC on August 8, 2008)

ANTIGENICS INC. 9,500,000 Shares Of Common Stock (Filed With SEC on July 10, 2008)

ANTIGENICS INC. 1999 EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on June 6, 2008)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 9, 2008)

EXCLUSIVE LICENSE AGREEMENT Table of Contents (Filed With SEC on May 9, 2008)

Master Services Agreement (Filed With SEC on May 9, 2008)

ANTIGENICS INC (Filed With SEC on April 10, 2008)

ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 10, 2008)

ANTIGENICS INC. (Filed With SEC on March 17, 2008)

SIXTH AMENDMENT TO LEASE (Filed With SEC on March 17, 2008)

CONSENT TO ASSIGNMENT OF LEASE (Filed With SEC on March 17, 2008)

FIRST AMENDMENT TO CONSENT TO SUBLEASE (Filed With SEC on March 17, 2008)

Side Letter (Filed With SEC on March 17, 2008)

Antigenics Consent Agreement (Filed With SEC on March 17, 2008)

Amendment No. 1 to the Exclusive License Agreement of July 1, 1988 (Filed With SEC on March 17, 2008)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on March 17, 2008)

ANTIGENICS INC 2004 EXECUTIVE INCENTIVE PLAN (Filed With SEC on March 17, 2008)

ANTIGENICS INC. 9,500,000 Shares Of Common Stock (Filed With SEC on March 14, 2008)

ANTIGENICS INC. 1999 Equity Incentive Plan, as amended (Filed With SEC on March 11, 2008)

ANTIGENICS INC (Filed With SEC on January 11, 2008)

ANTIGENICS INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 11, 2008)

EXHIBIT A (Filed With SEC on November 14, 2007)

LICENSE AGREEMENT (Filed With SEC on November 14, 2007)

SUPPLY AGREEMENT (Filed With SEC on November 14, 2007)

EXHIBIT A (Filed With SEC on September 5, 2007)

ANTIGENICS INC. 1999 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED (Filed With SEC on June 11, 2007)

ANTIGENICS INC. DIRECTORS DEFERRED COMPENSATION PLAN, As Amended (Filed With SEC on June 11, 2007)

SECOND AMENDMENT OF LEASE (Filed With SEC on May 10, 2007)

STANDARD FORM OF LOFT LEASE The Real Estate Board of New York, Inc. (Filed With SEC on November 9, 2006)

SENIOR SECURED CONVERTIBLE NOTE (Filed With SEC on October 31, 2006)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on October 31, 2006)

ANTIGENICS INC. GUARANTEE Dated as of October 30, 2006 (Filed With SEC on October 31, 2006)

ARONEX PHARMACEUTICALS, INC. (Filed With SEC on October 31, 2006)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 31, 2006)

THE JOHNS HOPKINS UNIVERSITY UNIFORM PROVISIONS FOR BOARD SERVICE (Filed With SEC on September 15, 2006)

LICENSE AGREEMENT BY AND BETWEEN ANTIGENICS, INC., A MASSACHUSETTS CORPORATION AND GLAXOSMITHKLINE BIOLOGICALSSA (Filed With SEC on August 9, 2006)

MANUFACTURING TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT (Filed With SEC on August 9, 2006)

ANTIGENICS INC. 1999 EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on June 19, 2006)

THIRD AMENDMENT TO LEASE (Filed With SEC on May 12, 2006)

CONSULTING AGREEMENT (Filed With SEC on March 28, 2006)

SUBLEASE (Filed With SEC on March 15, 2006)

ANTIGENICS INC. EXECUTIVE CHANGE OF CONTROL PLAN (Filed With SEC on March 15, 2006)

ANTIGENICS, INC 2003 EXECUTIVE INCENTIVE PLAN (Filed With SEC on March 15, 2006)

EX-10.1 Employment Agreement Dated 12/1/2005 (Filed With SEC on December 7, 2005)

EX-10.2 First Amendment of Employment Agreement (Filed With SEC on December 7, 2005)

EX-10.3 First Amendment of Employment Agreement (Filed With SEC on December 7, 2005)

EX-10.1 Employment agreement with Bruce Leicher (Filed With SEC on December 2, 2005)

Ex-10.1 Employment Agreement dated July 26, 2004 (Filed With SEC on May 10, 2005)

EX-10.4 Current Schedule Identifying the Directors and Executive Officers (Filed With SEC on March 31, 2005)

Ex-10.8 Research Agreement dated February 18, 1998 (Filed With SEC on March 31, 2005)

EX-10.26 Amendment No.1 of Research Agreement (Filed With SEC on March 31, 2005)

EX-10.28 Letter Agreement dated February 10, 2005 (Filed With SEC on March 31, 2005)

EX-4.1 Indenture, dated January 25, 2005 (Filed With SEC on January 25, 2005)

EX-4.2 Registration Rights Agreement, dated January 25, 2005 (Filed With SEC on January 25, 2005)

EX-10.1 Form of Non-Statutory Stock Option Certificate (Filed With SEC on December 15, 2004)

EX-10.2 2005 Cash Compensation (Filed With SEC on December 15, 2004)

EX-10.1 EMPLOYMENT AGREEMENT PETER THORNTON (Filed With SEC on August 9, 2004)

EX-10.1 FIRST AMENDMENT OF LEASE 8-15-03 (Filed With SEC on May 7, 2004)

Ex-10.4 Schedule to Indemnification Agreement (Filed With SEC on March 15, 2004)

Ex-10.27 Amendment No. 2 to Research Agreement (Filed With SEC on March 15, 2004)

5,000,000 Shares Common Stock ($0.01 Par Value) (Filed With SEC on February 4, 2004)

EX-10.1 MASTER SECURITY AGREEMENT (Filed With SEC on August 14, 2003)

EX-10.1 AIA DOCUMENT DATED 3/4/03 (Filed With SEC on May 15, 2003)

EX-10.2 LICENSE AGREEMENT DATED 5/25/01 (Filed With SEC on May 15, 2003)

EX-10.4 FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on March 27, 2003)

AMENDMENT OF FOUNDING SCIENTIST (Filed With SEC on March 27, 2003)

EX-10.30 Amendment #1 of Research Agreement (Filed With SEC on March 27, 2003)

EX-10.1 SUBLEASE AGREEMENT (Filed With SEC on August 13, 2002)

Category

Industry

Companies

Contracts

AGENUS INC Contracts & Agreements